A5042191575- Advanced Drug Delivery Systems
- Retinoids in leukemia and cellular processes
- Drug Solubulity and Delivery Systems
- Protein purification and stability
- RNA Interference and Gene Delivery
- Advancements in Transdermal Drug Delivery
- Monoclonal and Polyclonal Antibodies Research
- Synthesis and Characterization of Heterocyclic Compounds
- Nanoparticle-Based Drug Delivery
- Click Chemistry and Applications
- Hydrogels: synthesis, properties, applications
- Inhalation and Respiratory Drug Delivery
- Nitric Oxide and Endothelin Effects
- Ocular Surface and Contact Lens
- biodegradable polymer synthesis and properties
- Cell Adhesion Molecules Research
- RNA modifications and cancer
- Synthesis and biological activity
- Cancer-related Molecular Pathways
- Protease and Inhibitor Mechanisms
- Diabetes Treatment and Management
- Microfluidic and Capillary Electrophoresis Applications
- Biosimilars and Bioanalytical Methods
- Bone Tissue Engineering Materials
- Nanoplatforms for cancer theranostics
University of Michigan
2016-2025
BioSurfaces (United States)
2016-2025
Bio-Medical Science (South Korea)
1992-2012
The Ohio State University
1997-2005
Massachusetts Institute of Technology
1994-1998
An effervescent microneedle patch has been designed for rapid separation of drug-loaded microneedles and long-term contraception.
Capture and seal off all exits! Biomacromolecules are routinely microcapsulated in poly(lactic-co-glycolic acid) (PLGA) multiple complex steps that deleterious to the biomacromolecule. In contrast, PLGA encapsulation based on self-healing (see picture) shows high efficiency without protein damage enables stabilization slow release of proteins. Detailed facts importance specialist readers published as "Supporting Information". Such documents peer-reviewed, but not copy-edited or typeset. They...
In April 2016, the Food and Drug Administration approved first biosimilar monoclonal antibody (mAb), Inflectra/Remsima (Celltrion), based off original product Remicade (infliximab, Janssen). Biosimilars promise significant cost savings for patients, but unavoidable differences between innovator copycat biologics raise questions regarding interchangeability. this study, Remsima were examined by native mass spectrometry, ion mobility, quantitative peptide mapping. The levels of oxidation,...